Carol Werther


H.C. Wainwright Slashes Catabasis Pharmaceuticals Inc (CATB) Price Target in Half, But Sticks with Buy Rating

Catabasis Pharmaceuticals Inc (NASDAQ:CATB) shares are falling almost 8% amid an unfortunate setback with the firm’s MoveDMD Part B data read-out that failed …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts